| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |